B
SNY icon

Bailard’s Sanofi SNY Stock Holding History

Bailard’s Portfolio SNY Stock Details SNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.13M Sell
26,496
-2,295
-8% -$103K 0.02% 334
2026
Q1 		$1.39M Buy
28,791
+1,849
+7% +$86.2K 0.03% 276
2025
Q4 		$1.31M Sell
26,942
-114
-0.4% -$5.65K 0.03% 285
2025
Q3 		$1.28M Sell
27,056
-1,879
-6% -$90.7K 0.03% 300
2025
Q2 		$1.4M Buy
28,935
+1,199
+4% +$61.3K 0.03% 280
2025
Q1 		$1.54M Buy
27,736
+11,377
+70% +$616K 0.04% 249
2024
Q4 		$789K Buy
16,359
+220
+1% +$11.2K 0.02% 340
2024
Q3 		$930K Buy
16,139
+173
+1% +$9.34K 0.02% 319
2024
Q2 		$775K Sell
15,966
-533
-3% -$25.7K 0.02% 338
2024
Q1 		$802K Buy
16,499
+1,232
+8% +$60.2K 0.02% 340
2023
Q4 		$759K Sell
15,267
-346
-2% -$16.9K 0.02% 342
2023
Q3 		$837K Sell
15,613
-1,356
-8% -$72.3K 0.03% 296
2023
Q2 		$915K Buy
16,969
+23
+0.1% +$1.24K 0.03% 278
2023
Q1 		$922K Buy
16,946
+1,455
+9% +$70.8K 0.03% 279
2022
Q4 		$750K Buy
15,491
+1,814
+13% +$79.6K 0.03% 307
2022
Q3 		$520K Sell
13,677
-1,332
-9% -$59.4K 0.02% 358
2022
Q2 		$751K Buy
15,009
+341
+2% +$18.1K 0.03% 284
2022
Q1 		$753K Sell
14,668
-24
-0.2% -$1.24K 0.03% 323
2021
Q4 		$736K Sell
14,692
-1,289
-8% -$63.8K 0.02% 325
2021
Q3 		$770K Buy
15,981
+543
+4% +$27.6K 0.03% 313
2021
Q2 		$813K Buy
15,438
+568
+4% +$29.6K 0.03% 308
2021
Q1 		$735K Buy
14,870
+1,084
+8% +$52.1K 0.03% 307
2020
Q4 		$670K Buy
13,786
+1,689
+14% +$83.3K 0.03% 265
2020
Q3 		$607K Buy
12,097
+380
+3% +$19.6K 0.03% 260
2020
Q2 		$598K Buy
11,717
+1,188
+11% +$57.7K 0.03% 251
2020
Q1 		$460K Buy
+10,529
New +$504K 0.03% 239

Other funds holding SNY

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Bailard's SNY Position: Q2 2026 in Review

Bailard reduced its Sanofi (SNY) stake by 8% in Q2 2026, selling an estimated $103K and leaving 26,496 shares worth $1.13M. The position accounts for 0.02% of the portfolio, ranked #334.

Bailard first reported a position in SNY in Q1 2020 and has held it in 26 quarters since. The position peaked at $1.54M in Q1 2025. 716 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

  • Bailard held 26,496 shares of Sanofi worth $1.13M as of Q2 2026.
  • Bailard sold 2,295 Sanofi shares in Q2 2026, an estimated $103K.
  • Sanofi made up 0.02% of Bailard's portfolio in Q2 2026, its #334 holding.
  • Bailard first reported a position in Sanofi in Q1 2020 and has held it in 26 quarters since.
  • Bailard's Sanofi position peaked at $1.54M in Q1 2025.
  • 716 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on Bailard's 13F filing for Q2 2026, filed 30 Jul 2026.